Alkermes
medicinal chemistry or protein engineering approach for each target medicinal chemistry protein engineering guided internal medicinal chemistry design internal synthesis enables work in difficult to make space access to specialized chemistry capabilities protein degrader technology encoded libraries close integration with modeling team to guide protein design advanced protein engineering capabilities engineering tumor targeting platform fusion proteins | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
47 of 144
Related slides by other companies
Endava
Investor Presentation
September 2022
engineering run evolve product technology strategies design intelligent experiences testing continuous delivery secure development | Endava
DICE Therapeutics
Investor Presentation
March 2023
medicinal chemistry on a massive scale moor | DICE Therapeutics
argenx SE
Results
May 2021
leading antibody discovery and engineering | argenx SE
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io